High cholesterol often shows no symptoms, but a blue-grey ring around the iris, known as arcus senilis, can be a visible ...
Arcus Biosciences and Gilead Sciences are discontinuing a Phase 3 trial of an experimental cancer treatment after an interim review showed the therapy was unlikely to help patients live longer. Arcus ...
Arcus Biosciences, Inc. (NYSE:RCUS) on Friday announced the discontinuation of the Phase 3 STAR-221 study, being conducted in partnership with Gilead Sciences, Inc. (NASDAQ: GILD), due to futility. • ...
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, inflammatory ...
Surgeons at Rambam Eye Institute have made medical history. They restored sight to a legally blind patient using a fully 3D printed corneal implant grown entirely from cultured human corneal cells.
In a major breakthrough in human tissue replication, for the first time ever a 3D-printed cornea has been transplanted onto a legally blind patient's eye, successfully restoring their sight. That's ...
Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, inflammatory ...
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for ...
Fintel reports that on October 20, 2025, Wells Fargo maintained coverage of Arcus Biosciences (NYSE:RCUS) with a Overweight recommendation. Analyst Price Forecast Suggests 70.28% Upside As of ...
Credit: Glaukos. Epioxa does not require the removal of the corneal epithelium, a step usually required by traditional corneal cross-linking procedures, thereby minimizing pain and recovery time.
Like a windowpane, the transparent cornea is the outermost layer of tissue that protects our eyes. If this 500 to 600 micrometer-thin tissue is damaged by infections, injuries or malformations, vision ...
Please provide your email address to receive an email when new articles are posted on . Remarkable advances have occurred in corneal surgery in the past 10 years. These advances include simpler ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results